Silence Therapeutics - Investor Day Presentation by ALI MORTAZAVI
Silence Therapeutics - Investor Day Presentation by MIKE KHAN
Silence Therapeutics - Investor Day Presentation by DR. JÖRG KAUFMANN (Slides Only)
Silence Therapeutics - Investor Day Presentation by ALI MORTAZAVI (Slides Only)
Silence Therapeutics - Investor Day Presentation by MIKE KHAN (Slides Only)
Silence Therapeutics Morphing into Commercial Drug Company - Proactive Investors
Biotech Company of the Year 2014
Silence Therapeutics has created two powerful platforms and a strong pipeline to exploit the Company's impressive technological know-how and IP.
Combined, the RNAi and delivery platforms enable the development of multiple products to multiple drug targets allowing the developmentof novel therapeutics to diseases with high unmet medical need.
Silence Therapeutics wants to capitalise on these, its core competencies, to bring to market the next generation of therapeutic agents (RNAi therapeutics) alongside current small molecule and biological therapies.
The RNAi Hub is a comprehensive resource for people interested in the latest developments in RNAi Therapeutics. The RNAi Hub regroups in one location the news from the RNAi Therapeutics field, with a particular focus on the following areas of interest:
News Events Publications Companies Clinical Trials